The Dear Healthcare Professional Letter issued by Sanofi-aventis U.S. in December 2007 has been added.Also, links to prescribing information for healthcare professionals and patient package labeling with the safety-related revisions highlighted are included for the following DDAVP (desmopressin acetate) Sanofi-aventis, U.S. products: Nasal Spray, Rhinal Tube, Injection, and Tablets.
